Both probiotics and synbiotics significantly reduced AST in patients with NASH who were treated for not less than 12 weeks, but only synbiotics could significantly decrease ALT in this subgroup. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatohepatitis.